Pseudomonas aeruginosa adaptation in cystic fibrosis patients increases C5a levels and promotes neutrophil recruitment

References

• Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002;15(2):194–222.
   PubMed Web of Science ®Google Scholar
• Winstanley C, O’Brien S, Brockhurst MA. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol. 2016;24(5):327–337.
   PubMed Web of Science ®Google Scholar
• Marvig RL, Sommer LM, Molin S, et al. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet. 2015;47(1):57–64.
   PubMed Web of Science ®Google Scholar
• Nguyen D, Singh PK. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc Natl Acad Sci USA. 2006;103(22):8305–8306.
   PubMed Web of Science ®Google Scholar
• Ricklin D, Hajishengallis G, Yang K, et al. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785–797.
   PubMed Web of Science ®Google Scholar
• Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol. 2004;4(2):133–142.
   PubMed Web of Science ®Google Scholar
• Conway Morris A, Kefala K, Wilkinson, TS, et al. C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. Am J Respir Crit Care Med. 2009;180(1):19–28.
   PubMed Web of Science ®Google Scholar
• Wood AJ, Vassallo AM, Ruchaud-Sparagano MH, et al. C5a impairs phagosomal maturation in the neutrophil through phosphoproteomic remodeling. J Clin Invest Insight. 2020;5. e137029.
   PubMed Web of Science ®Google Scholar
• Sass LA, Hair PS, Perkins AM, et al. Complement effectors of inflammation in cystic fibrosis lung fluid correlate with clinical measures of disease. PLoS ONE. 2015;10(12):e0144723.
   PubMed Web of Science ®Google Scholar
• RB F Jr, Robbins RA, Squier SU, et al. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Pediatr Res. 1986;20(12):1258–1268.
   PubMed Web of Science ®Google Scholar
• Hair PS, Sass LA, Vazifedan T, et al. Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity. PLoS One. 2017;12(3):e0173257.
   PubMed Web of Science ®Google Scholar
• López-Causapé C, Rojo-Molinero E, Cabot G, et al. Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. PLoS One. 2013;8(8):e71001.
   PubMed Web of Science ®Google Scholar
• Barbier M, Oliver A, Rao J, et al. Novel phosphorylcholine-containing protein of Pseudomonas aeruginosa chronic infection isolates interacts with airway epithelial cells. J Infect Dis. 2008;197(3):465–473.
   PubMed Web of Science ®Google Scholar
• Casilag F, Lorenz A, Krueger J, et al. The LasB elastase of Pseudomonas aeruginosa acts in concert with alkaline protease AprA to prevent flagellin-mediated immune recognition. Infect Immun. 2015;84(1):162–171.
   PubMed Web of Science ®Google Scholar
• Kirchner S, Fothergill JL, Wright EA, et al. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung. J Vis Exp. 2012; (64):e3857. DOI:10.3791/3857.
   PubMed Web of Science ®Google Scholar
• Watford WT, Ghio JA, Wright JR. Complement-mediated host defense in the lung. Am J Physiol Lung Cell Mol Physiol. 2000;279(5):790–798.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Owings JP, Kuiper EG, Prezioso SM, et al. Pseudomonas aeruginosa EftM Is a thermoregulated methyltransferase. J Biol Chem. 2016;291(7):3280–3290.
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor NY: Cold Spring Harbor Laboratory Press; 1989.
   Google Scholar
• Mosca T, Forte WC. Comparative efficiency and impact on the activity of blood neutrophils isolated by Percoll, Ficoll and spontaneous sedimentation methods. Immunol Invest. 2016;45(1):29–37.
   PubMed Web of Science ®Google Scholar
• Laarman AJ, Bardoel BW, Fernie J, et al. Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways. J Immunol. 2012;188(1):386–393.
   PubMed Web of Science ®Google Scholar
• Hong YQ, Ghebrehiwet B. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin Immunol Immunopathol. 1992;62(2):133–138.
   PubMedGoogle Scholar
• Cerquetti MC, Sordelli DO, Bellanti JA, et al. Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect Immun. 1986;52(3):853–857.
   PubMed Web of Science ®Google Scholar
• Hopken UE, Lu B, Gerard NP, et al. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature. 1996;383(6595):86–89.
   PubMed Web of Science ®Google Scholar
• Vitkauskiene A, Scheuss S, Sakalauskas R, et al. Pseudomonas aeruginosa strains from nosocomial pneumonia are more serum resistant than P. aeruginosa strains from noninfectious respiratory colonization processes. Infection. 2005;33(5–6):356–361.
   PubMed Web of Science ®Google Scholar
• Wexler DE, Chenoweth DE, Cleary PP. Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A. 1985;82(23):8144–8148.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Nagano Y, Nagano N, et al. Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing. Infect Immun. 1995;63(12):4764–4769.
   PubMed Web of Science ®Google Scholar
• Cantin AM, Hartl D, Konstan MW, et al. Inflammation in cystic fibrosis lung disease: pathogenesis and therapy. J Cyst Fibros. 2015;14(4):419–430.
   PubMed Web of Science ®Google Scholar
• Smith EE, Buckley DG, Wu Z, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A. 2006;103(22):8487–8492.
   PubMed Web of Science ®Google Scholar
• D’Argenio DA, Wu M, Hoffman LR, et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol. 2007;64(2):512–533.
   PubMed Web of Science ®Google Scholar
• Hoffman LR, Kulasekara HD, Emerson J, et al. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros. 2009;8(1):66–70.
   PubMed Web of Science ®Google Scholar
• Feltner JB, Wolter DJ, Pope CE, et al. LasR variant cystic fibrosis isolates reveal an adaptable quorum-sensing hierarchy in Pseudomonas aeruginosa. mBio. 2016;7(5):e01513–16.
   PubMed Web of Science ®Google Scholar
• LaFayette SL, Houle D, Beaudoin T, et al. Cystic fibrosis–adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses. Sci Adv. 2015;1(6):e1500199.
   PubMed Web of Science ®Google Scholar
• Hennemann LC, LaFayette SL, Malet JK, et al. LasR-deficient Pseudomonas aeruginosa variants increase airway epithelial mICAM-1 expression and enhance neutrophilic lung inflammation. PLoS Pathog. 2021;17(3):e1009375.
   PubMed Web of Science ®Google Scholar
• Alexis NE, Muhlebach MS, Peden DB, et al. Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients. J Cyst Fibros. 2006;5(1):17–25.
   PubMed Web of Science ®Google Scholar